CIK 0001595097
- Non-accelerated filer
- Smaller reporting company
Corbus Pharmaceuticals Holdings, Inc.
Sign in to watch- Ticker
- CRBP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464348039
- Phone
- +1 617-963-0103
- Business address
- 500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
- Former names
- SAV Acquisition Corp
- 4 Open-market buy Chief Financial Officer bought 30,800 shares at $5.12 ($157,696)
- 4 Open-market buy Chief Financial Officer bought 17,900 shares at $3.92 ($70,168)
- 4 Open-market buy Director bought 1,800 shares at $3.77 ($6,786)
- 4 Exercise or conversion Chief Executive Officer acquired 20,000 shares (option exercise)
- 4 Open-market buy Chief Financial Officer bought 148,960 shares at an average $3.32 ($494,032)
- 4 Open-market buy Chief Medical Officer bought 38,000 shares at $3.15 ($119,844)
- 4 Open-market buy Chief Medical Officer bought 1,935 shares at $3.10 ($5,999)
- 4 Open-market buy Chief Executive Officer bought 1,500 shares at $3.34 ($5,010)
- 4 Open-market buy Chief Medical Officer bought 2,570 shares at $3.52 ($9,046)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Financial Officer bought 27,250 shares at $2.37 ($64,583)
- 4 Open-market buy Chief Executive Officer bought 2,125 shares at $2.40 ($5,100)
- 4 Open-market buy Chief Financial Officer bought 30,000 shares at $2.39 ($71,700)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 13 of 17 · 340 filings